Thermo Fisher Scientific Inc (TMO)
NYSE · Healthcare · Diagnostics & Research
Thermo Fisher Scientific Inc is a Healthcare company with a market capitalization of $190.65B, a trailing P/E ratio of 28.2, and a dividend yield of 0.35%.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | April 23, 2026 | $5.44 | $5.24 | +3.8% |
| Q4 2025 | January 29, 2026 | $6.57 | $6.45 | +1.9% |
| Q3 2025 | October 22, 2025 | $5.79 | $5.50 | +5.3% |
| Q2 2025 | July 23, 2025 | $5.36 | $5.23 | +2.5% |
| Q1 2025 | April 23, 2025 | $5.15 | $5.10 | +1.0% |
| Q4 2024 | January 30, 2025 | $6.10 | $5.94 | +2.7% |
Other Diagnostics & Research Stocks
Frequently Asked Questions
What is Thermo Fisher Scientific Inc's market cap?
As of June 29, 2026, Thermo Fisher Scientific Inc (TMO) has a market capitalization of $190.65B.
What is Thermo Fisher Scientific Inc's P/E ratio?
Thermo Fisher Scientific Inc trades at a trailing price-to-earnings (P/E) ratio of 28.2. Its forward P/E is 20.6.
Does Thermo Fisher Scientific Inc pay a dividend?
Yes — Thermo Fisher Scientific Inc pays a dividend yielding 0.35%, an annual payout of $1.76 per share.
What sector is TMO in?
Thermo Fisher Scientific Inc is in the Healthcare sector, specifically the Diagnostics & Research industry.
What was Thermo Fisher Scientific Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), Thermo Fisher Scientific Inc reported revenue of $44.56B and net income of $6.74B.
Ask your own questions about TMO
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.